AzTrials
AzTrials

PeriodontitisNCT05667376

Efficacy of Curcumin Gel Combined With Non-surgical Periodontal Therapy on Salivary Procalcitonin Level in the Treatment of Periodontitis Patients

A study testing Local drug delivery and curcumin gel in people with Periodontitis, run by Reham abdelfatah at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objectives: To evaluate the efficacy of curcumin gel as an adjunct to scaling and root planing (SRP) on the salivary procalcitonin level in the treatment of periodontitis. Materials and methods: seventy patients (n=70) were selected from the Department of Oral Medicine and Periodontology, Faculty of Dentistry… Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Periodontitis
What is being tested?
Local drug delivery and curcumin gel
Could I receive a placebo?
No, everyone receives an active treatment
How many people
54 participants
Where
1 siteEgypt
Study dates
1 Jan 2021to 30 May 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • inclusion criteria were participants of both sexes, between the ages of thirty and fifty -five years old with periodontitis (stage II grade A).

Who cannot join

  • exclusion criteria involved participants with known systemic diseases, pregnant and lactating patients, tobacco users (smoking /chewing), history of antibiotic and periodontal therapy in the last three months, and participants who weren't compliant with oral hygiene procedures.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Reham Ahmed Abdel-Fatah

    Al Mansurah, 35516

Other trials in Egypt

About this study

Official title: Efficacy of Curcumin Gel as an Adjunct to Scaling and Root Planing on Salivary Procalcitonin Level in the Treatment of Periodontitis Patients: Randomized Controlled Clinical Trial

Objectives: To evaluate the efficacy of curcumin gel as an adjunct to scaling and root planing (SRP) on the salivary procalcitonin level in the treatment of periodontitis.

Materials and methods: seventy patients (n=70) were selected from the Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University, sixteen patients (n=16) were excluded as eight patients (n=8) weren't met the inclusion criteria, and other eight patients were divided into (n= 4) declined to participate with (n=4) were excluded due to pregnancy and lactation. The participants fifty -four patients were classified into three groups: group I (healthy individuals), group II (SRP group), and group III (curcumin gel group). Patients in groups II and III included stage II grade A periodontitis. Patients in group II were treated with SRP only while in group III curcumin gel was applied weekly for four weeks after SRP had been completed. Clinical indices (plaque index (PI), gingival index (GI), clinical attachment level (CAL), and probing depth (PD)) and saliva samples for procalcitonin (PCT) assessment using an enzyme-linked immunosorbent assay (ELISA) test were collected and measured at baseline and again after six weeks.

Read the detailed description

Study population The randomized controlled clinical trial included fifty-four participants selected from the Department of Oral Medicine and Periodontology Outpatient Clinic, Faculty of Dentistry, Mansoura University from January 2021 to May 2021. Thirty-six patients with periodontitis (stage II grade A) and eighteen healthy volunteers (negative control group) participated in the study.

  1. Inclusion criteria for patient selection: The selected patients included:
  2. Participants of both sexes between the ages of thirty to fifty -five years old
  3. Participants with periodontitis (stage II grade A with PD of 3-5 mm and CAL of 3-4mm).
  4. Exclusion criteria included:
  5. Participants with known systemic diseases
  6. Pregnant and lactating participants.
  7. Tobacco (smoking/chewing).
  8. History of antibiotic and periodontal therapy in the last 3 months.
  9. Participants who weren't compliant with oral hygiene procedures.

Study Design: The selected patients will be divided into 3 groups:

Group 1 (study group): patients are to be treated with turmeric gel as an adjunct to Scaling and root planing.

Group 2 (positive control group): patients are to be treated with only Scaling and root planing.

Group 3 (negative control group): patients with clinically healthy gingiva.

  1. Periodontal Assessment:

All these measurements will be assessed :

  1. Plaque Index according to Silness P. Loe H 1964.
  2. Gingival Bleeding Index according to Ainamo \& Bay 1975.
  3. Probing pocket depth (PPD) is measured from the free gingival margin to the base of the pocket.
  4. Clinical attachment level (CAL) is measured from the cement enamel junction to the base of the pocket.

For all periodontitis patients, the Clinical assessment will be performed at baseline and 45 days after periodontal treatment ( either Scaling, root planning, and injection of gel or Scaling and root planning alone ).

This study was conducted following guidelines regulating research work on human subjects of the Faculty of Dentistry, Mansoura University, and the study protocol was reviewed and approved by the Research Ethics Committee of the Faculty of Dentistry, Mansoura University, Egypt. (Number: A01031120).

Sample size calculation Sample size calculation was based on mean superoxide dismutase (SOD) after treatment between the study and control group retrieved from a previous study (Elavarasu et al., 2016). Using G*power version 3.0.10 to calculate sample size based on the effect size of 0.828, 2-tailed test, α error =0.05, d power = 90.0% the total calculated sample size was 18 in each group at least.

Pretreatment period Participants were informed about the purpose of the study and screened for eligibility. They also were informed about the treatment received and the steps done, including non-surgical treatment and gel application with the associated risks, possible effects, and other treatment options available. The participants understood this explanation in broad terms according to the rules of the ethical committee of the Faculty of Dentistry, Mansoura University. Additionally, they acknowledged that they would be required to attend the periodic recall visits and that they are legally competent to give written informed consent before performing any required steps.

Randomization and study groups The patients with periodontitis groups were randomly selected into either group II or III using the coin toss method. Hence the study groups were classified into three groups as follows, group I (negative control group): eighteen subjects with clinically healthy gingiva were selected to participate in the study as a reference group, and group II (positive control group): eighteen patients with periodontitis (stage II grade A) were selected and treated with non-surgical periodontal therapy (SRP) only, and group III (study group): eighteen patients with periodontitis (stage II grade A) were selected and treated with SRP followed by curcumin gel application.

Saliva sample collection:

Saliva sample collection was accomplished using the swabbing method. It was performed by introducing a cotton pad into the mouth at the orifices of major salivary glands. The subjects were asked to chew the cotton pad to get soaked in the saliva. The saliva-soaked pad was removed and placed in a sterile test tube (sterile Eppendorf tube) and centrifuged at 3000 rounds per minute (RPM) for approximately 10 minutes and then kept frozen at -20°c till the time of analysis.

Procedures for curcumin gel preparation:

Curcumin Gel Preparation: The gel will be prepared in the Department of Pharmacology, Faculty of Pharmacy, Mansoura University. Preparation of 2% curcumin gel by simple dispersion method as shown: Formula to prepare 2%curcumin gel Ingredients Quantity Carpacol 2 gm Polymer (HPMC) 2 gm Curcumin 5 ml Propylene glycol 0.2 ml Sodium benzoate q.s Triethanolamine q.s. to make 100 ml Distilled water 2g

(HPMC =hydroxy propyl methyl cellulose ; q.s.=quantity sufficient) Carbopol 940 will be soaked in purified water containing 0.2% w/v sodium benzoate overnight. Using tissue homogenizer hydroxypropyl methylcellulose (HPMC) solution will be mixed in propylene glycol. 0. 2 mg of curcumin (Sigma, St. Lo, USA) will be transferred into HPMC solution and homogenized. This drug solution will be transferred to a carbopol solution and homogenized. Triethanolamine will be added in a quantity sufficient (q.s.) to neutralize the pH. Then, distilled water will be added to make q.s. to 100 ml. The gel will be stored at ambient temperature. The prepared gel will be tested for microbial growth by incubation for 24 hours. If no microbial growth will be observed, the final preparation will then be transferred into glass containers and will be stored in the refrigerator (temperature ranging from 2-10°C and 80-85% humidity)

SRP procedures:

At the beginning of treatment, the periodontitis patients were treated with SRP using both special tipped ultrasonic scalers and manual Gracey curettes until a smooth tooth/root surface was achieved. The SRP procedure was repeated once again (if necessary) and instructions were given to the patients to maintain good oral hygiene measures during the treatment period. Brushing and flossing techniques were taught to all participants using patient education videos and demonstrated on study models. No antibiotics or mouthwashes were prescribed during treatment. All patients were recalled weekly during the study period (which was carried out for six weeks) for reinforcement of oral hygiene measures and curcumin gel application inside the only selected periodontal pockets of group III as it was applied weekly for four weeks after completing SRP.

Curcumin Gel Application:

Following SRP procedures, only selected periodontal pockets (pockets diagnosed with stage II grade A, PD of 3-5 mm, and CAL of 3-4mm) within group III were delivered with 2% curcumin gel sub-gingivally using a disposable 2 ml syringe with a blunt needle (bent 130° at the shank). The application of gel was initiated from the base of the pocket to ensure the gel reached the whole pocket depth. This was accomplished by a plastic syringe with a flexible metal needle with a large gauge (similar to those used for acid etchant application).

This procedure continued until the pocket was filled. Care was taken to apply the gel without traumatizing or damaging the periodontal tissues. After insertion of the curcumin gel, the region was secured with a cotton pack, and the patients were advised not to eat or drink for at least two hours following gel administration. They were also advised not to brush the treated areas or floss /use interproximal cleaning devices for at least twelve hours postoperatively and to avoid eating hard and abrasive foods that could traumatize the gingiva. The treatment was followed-up by weekly recalls after gel application for reinforcement of oral hygiene measurements and subsequent gel reapplication. The curcumin gel was applied weekly for four weeks after completing SRP.

Periodontal measurements ( plaque Index (PI ), gingival index (GI), probing depth (PD), and clinical attachment level (CAL) were recorded at baseline for all groups and again six weeks after periodontal treatment for both group II and group III using a periodontal probe as most studies outcomes were assessed based on either short-term effects (studies with a 2-weeks follow-up, acceptability range ±3 days) or long-term effects (studies with a 4-weeks follow-up, acceptability range ±3 days). Measurements were done by a blinded single examiner (SE) who did not know the identity of the groups in which patients were included.

Intra-examiner reliability To achieve intra- examiner calibration, periodontal measurements of 10 patients were performed twice within 2 days before randomized clinical trial (RCT) conduction. Calibration was approved when measurements of PD and CAL in the two instances were within a 1 mm variance in more than 90% of all measurements.

Laboratory assessment of PCT level The salivary samples were collected from all participants at baseline and once more from both group II and group III after six weeks. The samples were kept in sterile Eppendorf tubes, centrifuged at 3000 RPM for approximately 10 minutes, and frozen at -20°c until the time of analysis by ELISA test to assess salivary PCT (according to manufacturer instructions).

Statistical Assessment:

Data will be analyzed using SPSS (statistical package for social sciences) version 22. Qualitative data will be presented as numbers and percentages, Quantitative data will be tested for normality by the Shapiro-Wilk test and then described as mean and standard deviation for normally distributed data and median and range for non-normally distributed. The appropriate statistical test will be applied according to the data type with the following suggested tests: Chi-Square for categorical variable. One Way ANOVA and Kruskal-Wallis tests U test for continuous variables. Repeated Measures ANOVA and Freidman tests for comparing pre, post, and follow-up readings. Pearson and spearman correlation will be used to correlate between continuous variables

Conditions
Periodontitis
Being tested
Local drug delivery, curcumin gel
Medical subject headings
Periodontitis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Local drug deliveryOther

    Local application of curcumin gel into the periodontal pocket

  • curcumin gelDrug

    curcumin gel

Study groups in NCT05667376
Study groupRoleWhat they receive
Study groupOtherStudy group treated with curcumin gel
Receives: Other: Local drug delivery; Drug: curcumin gel

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Probing pocket depth reduction

    Clinical attachment level gain

    Measured: Six weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Dec 2022
  2. Study start1 Jan 2021
  3. Primary completion30 May 2021
  4. Study completion30 May 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
patients (n=70) were selected from the Department of Oral Medicine and Periodontology, Faculty of Dentistry, Mansoura University, sixteen patients (n=16) were excluded as eight patients (n=6) weren't met the inclusion criteria and the other eight patients (n= 6) declined to participate with (n=4) were excluded due to pregnancy and lactation. The participants fifty -four patients were classified into three groups: group I (healthy individuals), group II (SRP group), and group III (curcumin gel group). Patients in group II and group III included patients with stage II grade A periodontitis. Patients in group II were treated with SRP only while in group III curcumin gel was applied weekly for four weeks after SRP had been completed.
Masking
None (open label)
Enrolment
54 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05667376
Sponsor's protocol ID
A01031120
Status last verified
Oct 2023
First submitted
3 Oct 2022
Last updated
19 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Abdel-Fatah R, Mowafey B, Baiomy A, Elmeadawy S. Efficacy of curcumin gel as an adjunct to scaling and root planing on salivary procalcitonin level in the treatment of patients with chronic periodontitis: a randomized controlled clinical trial. BMC Oral Health. 2023 Nov 19;23(1):883. doi: 10.1186/s12903-023-03512-y.

    PubMed 37981665

Questions about this trial

What is this clinical trial studying?

A study testing Local drug delivery and curcumin gel in people with Periodontitis, run by Reham abdelfatah at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Probing pocket depth reduction (time frame: Six weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05667376, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in